Search results

Jump to navigation Jump to search

Page title matches

  • New drug application
    ...nt for those specific conditions. Prior to the NDA, the '''Investigational New Drug Application (IND)''' effectively approves the use of the drug in specific [[randomized
    5 KB (808 words) - 15:51, 30 August 2009
  • New Drug Application
    #REDIRECT [[New drug application]]
    34 bytes (4 words) - 20:31, 14 October 2008
  • New drug application/Definition
    298 bytes (42 words) - 14:43, 4 October 2008
  • New drug application/Related Articles
    Auto-populated based on [[Special:WhatLinksHere/New drug application]]. Needs checking by a human.
    525 bytes (67 words) - 18:59, 11 January 2010

Page text matches

  • New Drug Application
    #REDIRECT [[New drug application]]
    34 bytes (4 words) - 20:31, 14 October 2008
  • Alfuzosin
    ...pprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ Abbreviated New Drug Application] (ANDA) in 2009.<ref>[http://www.accessdata.fda.gov/scripts/cder/drugsatfda
    1 KB (142 words) - 11:47, 2 February 2023
  • Tamsulosin
    ...pprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ Abbreviated New Drug Application] (ANDA) in 2007.<ref>[http://www.accessdata.fda.gov/scripts/cder/drugsatfda
    1 KB (142 words) - 14:35, 2 February 2023
  • Bupropion
    ...pprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ Abbreviated New Drug Application] (ANDA) in 1999.<ref>[http://www.accessdata.fda.gov/scripts/cder/drugsatfda
    1 KB (163 words) - 14:10, 9 October 2009
  • Omeprazole
    ...pprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ Abbreviated New Drug Application] (ANDA) in 2008.<ref>{{FDA-Drug_Details|075347}}</ref> In 4/2008, a delayed
    2 KB (199 words) - 14:07, 2 February 2023
  • Rosuvastatin
    ...pprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ Abbreviated New Drug Application] (ANDA) in 2011.<ref>{{FDA-Drug_Details|202172}}</ref>
    2 KB (265 words) - 14:07, 2 February 2023
  • New drug application/Related Articles
    Auto-populated based on [[Special:WhatLinksHere/New drug application]]. Needs checking by a human.
    525 bytes (67 words) - 18:59, 11 January 2010
  • Adderall
    ...pprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ Abbreviated New Drug Application] (ANDA) in 2002.<ref>[http://www.accessdata.fda.gov/scripts/cder/drugsatfda
    3 KB (410 words) - 11:51, 2 February 2023
  • Tenofovir
    ...owDrugsareDevelopedandApproved/ApprovalApplications/NewDrugApplicationNDA/ New Drug Application] (NDA) in 2001.<ref>{{FDA-Drug_Details|021356}}</ref> ...pprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ Abbreviated New Drug Application] (ANDA) in 2009.<ref>{{FDA-Drug_Details|078800}}</ref> The generic ANDA was
    2 KB (335 words) - 14:35, 2 February 2023
  • Finasteride
    ...pprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ Abbreviated New Drug Application] (ANDA) in 200_.<ref>[http://www.accessdata.fda.gov/scripts/cder/drugsatfda
    3 KB (403 words) - 13:22, 2 February 2023
  • Zidovudine
    ...pprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ Abbreviated New Drug Application] (ANDA) in 1995.<ref>[http://www.accessdata.fda.gov/scripts/cder/drugsatfda
    3 KB (394 words) - 07:05, 17 October 2009
  • Valacyclovir
    ...pprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ Abbreviated New Drug Application] (ANDA) in 2007.<ref>[http://www.accessdata.fda.gov/scripts/cder/drugsatfda
    4 KB (502 words) - 14:34, 2 February 2023
  • New drug application
    ...nt for those specific conditions. Prior to the NDA, the '''Investigational New Drug Application (IND)''' effectively approves the use of the drug in specific [[randomized
    5 KB (808 words) - 15:51, 30 August 2009
  • Buprenorphine
    ...owDrugsareDevelopedandApproved/ApprovalApplications/NewDrugApplicationNDA/ New Drug Application] (NDA) by the FDA in 2002.<ref>[http://www.accessdata.fda.gov/scripts/cder/ ...pprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ Abbreviated New Drug Application] (ANDA) in 1996.<ref>[http://www.accessdata.fda.gov/scripts/cder/drugsatfda
    6 KB (820 words) - 11:49, 2 February 2023
  • Defibrillator/Related Articles
    {{r|New drug application}}
    630 bytes (80 words) - 15:53, 11 January 2010
  • Carboplatin
    ...pprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ Abbreviated New Drug Application] (ANDA) in 2003.<ref>[http://www.accessdata.fda.gov/scripts/cder/drugsatfda
    4 KB (489 words) - 08:06, 27 June 2010
  • Thiazolidinedione
    ...pprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ Abbreviated New Drug Application] (ANDA) in 2004.<ref>[http://www.accessdata.fda.gov/scripts/cder/drugsatfda ...pprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ Abbreviated New Drug Application] (ANDA) in 2005.<ref>[http://www.accessdata.fda.gov/scripts/cder/drugsatfda
    6 KB (804 words) - 14:35, 2 February 2023
  • Mirtazapine
    ...pprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ Abbreviated New Drug Application] (ANDA) in 2004.<ref>{{FDA-Drug_Details|076119}}</ref>
    3 KB (422 words) - 14:08, 2 February 2023
  • Eplerenone
    ...pprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ Abbreviated New Drug Application] (ANDA) on July 30, 2008 (Apotex)<ref>{{FDA-Drug_Details|078482}}</ref> and
    3 KB (447 words) - 13:22, 2 February 2023
  • Fidaxomicin
    ...owDrugsareDevelopedandApproved/ApprovalApplications/NewDrugApplicationNDA/ New Drug Application] (NDA) in 2011.<ref>{{FDA-Drug_Details|201699}}</ref>
    2 KB (243 words) - 13:18, 2 February 2023
  • Food and Drug Administration/Related Articles
    {{r|New drug application}}
    4 KB (505 words) - 16:36, 11 January 2010
  • Mycophenolate mofetil
    ...pprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ Abbreviated New Drug Application] (ANDA) in 2008.<ref>{{FDA-Drug_Details|065379}}</ref>
    6 KB (836 words) - 14:09, 2 February 2023
  • Ezetimibe
    ...pprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ Abbreviated New Drug Application] (ANDA) in 2009.<ref>{{FDA-Drug_Details|078560}}</ref>
    6 KB (751 words) - 13:17, 2 February 2023
  • Escitalopram
    ...owDrugsareDevelopedandApproved/ApprovalApplications/NewDrugApplicationNDA/ New Drug Application] (NDA) in 2002.<ref>[http://www.accessdata.fda.gov/scripts/cder/drugsatfda/
    4 KB (501 words) - 13:18, 2 February 2023
  • Venlafaxine
    ...owDrugsareDevelopedandApproved/ApprovalApplications/NewDrugApplicationNDA/ New Drug Application] (NDA) in 1993.<ref>{{FDA-Drug_Details|020151}}</ref> A generic version wa
    3 KB (390 words) - 14:34, 2 February 2023
  • Gabapentin
    ...pprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ Abbreviated New Drug Application] (ANDA) in 2003.<ref>[http://www.accessdata.fda.gov/scripts/cder/drugsatfda
    7 KB (844 words) - 13:17, 2 February 2023
  • Generic drug
    === Abbreviated New Drug Application === ...ications/AbbreviatedNewDrugApplicationANDAGenerics/default.htm Abbreviated New Drug Application] (or "ANDA") with the [[Food and Drug Administration]] (FDA) and seeks to d
    18 KB (2,553 words) - 13:17, 2 February 2023
  • Spironolactone
    ...pprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ Abbreviated New Drug Application] (ANDA) on July 29, 1999.<ref>{{FDA-Drug_Details|040353}}</ref>
    9 KB (1,159 words) - 14:09, 2 February 2023
  • Food and Drug Administration
    ...ability and bioavailablility, and suggested packaging and labeling, as a [[new drug application]] (NDA) to the FDA. The NDA is then reviewed by teams of FDA employees, inc ...per study and testing. The drug industry must pay "user fees" with every [[new drug application]]. A drug is given "fast-track" status if it meets a medical need not curre
    40 KB (5,751 words) - 04:07, 19 September 2013
  • AIDS
    ...owDrugsareDevelopedandApproved/ApprovalApplications/NewDrugApplicationNDA/ New Drug Application] (NDA) by the FDA in 1987.<ref>[http://www.accessdata.fda.gov/scripts/cder/
    20 KB (2,873 words) - 11:51, 2 February 2023
  • Human Immunodeficiency Virus Type 1
    ...owDrugsareDevelopedandApproved/ApprovalApplications/NewDrugApplicationNDA/ New Drug Application] (NDA) by the FDA in 1987.<ref>[http://www.accessdata.fda.gov/scripts/cder/
    31 KB (4,264 words) - 13:22, 2 February 2023
  • Randomized controlled trial/Citable Version
    Trials of potential treatments, for ethical reasons, tend to involve [[New Drug Application|multiple stages]], starting with small safety tests of the drug or other th ...onsent]] for participation in a trial. In the United States, there is an [[New drug application| approval procedure]] for clinical trials in human subjects, whether for re
    79 KB (10,925 words) - 14:12, 2 February 2023
  • Influenza
    ...cy authorization for the use of intravenous peramavir, which had been in [[New Drug Application|Phase III clinical trials]]. <ref name=FDA-EUA-par>{{citation
    37 KB (5,103 words) - 13:22, 2 February 2023
  • Randomized controlled trial
    Trials of potential treatments, for ethical reasons, tend to involve [[New Drug Application|multiple stages]], starting with small safety tests of the drug or other th ...onsent]] for participation in a trial. In the United States, there is an [[New drug application| approval procedure]] for clinical trials in human subjects, whether for re
    87 KB (12,105 words) - 14:08, 2 February 2023
Retrieved from "https://citizendium.org/wiki/Special:Search"